Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antiparkinsonism Agents
Chapter 24
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Parkinson
’
s Disease
•
Progressive chronic neurological disorder
•
May develop in people of any age
•
Usually effects those who are past middle age and
entering their 60s
•
No cure for the disease
•
Therapy is aimed at management of signs and symptoms
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Progression of Parkinson
’
s Disease
•
Lack of Coordination
•
Rhythmic Tremors
•
Rigidity/Weakness
•
Trouble Maintaining Position or Posture
•
Bradykinesia
•
Difficulty Walking
•
Drooling and Affected Speech
•
Mask-like Expressions
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Theories About the Cause of Parkinson
’
s
Disease
•
Viral Infection
•
Blows to the Head
•
Brain Infection
•
Atherosclerosis
•
Exposure to Certain Drugs
•
Environmental Factors
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Degeneration of Neurons that Leads
to Parkinson
’
s Disease
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Management of Care for Patients with
Parkinson
’
s Disease
•
Encourage Patients To:
–
Be as active as possible
–
Perform exercises
–
Maintain independency with ADL
’
s as long as possible
–
Follow drug protocols
•
Caregivers Should:
–
Monitor adverse effects
–
Provide encouragement and support
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anticholinergics Used to Treat
Parkinson
’
s Disease
•
Benztropine (
Cogentin
)
•
Biperiden (
Akineton
)
•
Diphenhydramine (
Benadryl
)
•
Procyclidine (
Kemadrin
)
•
Trihexyphenidyl (
Artane
)
You've reached the end of your free preview.
Want to read all 25 pages?
- Summer '16
- Wolters Kluwer Health, Lippincott Williams & Wilkins
